Do histone deacetylase inhibitors have a place in the treatment of myelodysplastic syndromes?

被引：0
|
作者：
Gore, S. D. [1 ]
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70037-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [1] DNA methyltransferase and histone deacetylase inhibitors in the treatment of Myelodysplastic syndromes
    Griffiths, Elizabeth A.
    Gore, Steven D.
    SEMINARS IN HEMATOLOGY, 2008, 45 (01) : 23 - 30
  • [2] Deacetylase inhibitors for the treatment of myelodysplastic syndromes
    Jabbour, Elias
    Garcia-Manero, Guillermo
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1205 - 1212
  • [3] Histone Deacetylase Inhibitors in Myelodysplastic Syndrome
    Selene, Insija Ilyas
    Jose, Jemin Aby
    Sardar, Muhammad
    Shah, Zunairah
    Shafqat, Madeeha
    Faridi, Warda
    Malik, Mustafa Nadeem
    Yasir, Muhammad
    Khalil, Muhammad Jahanzeb
    Aslam, Shehroz
    Qureshi, Anum
    Rafiyath, Shamudeen
    Anwer, Faiz
    BLOOD, 2018, 132
  • [4] Histone deacetylase inhibitors in myelodysplastic syndrome
    Bhalla, K
    List, A
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (04) : 595 - 611
  • [5] Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: "To Be or Not to Be Acetylated"?
    Stintzing, Sebastian
    Kemmerling, Ralf
    Kiesslich, Tobias
    Alinger, Beate
    Ocker, Matthias
    Neureiter, Daniel
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [6] Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia
    Quintas-Cardama, A.
    Santos, F. P. S.
    Garcia-Manero, G.
    LEUKEMIA, 2011, 25 (02) : 226 - 235
  • [7] Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia
    A Quintás-Cardama
    F P S Santos
    G Garcia-Manero
    Leukemia, 2011, 25 : 226 - 235
  • [8] Lost in translation? Ten years of development of histone deacetylase inhibitors in acute myeloid leukemia and myelodysplastic syndromes
    Stahl, Maximilian
    Gore, Steven D.
    Vey, Norbert
    Prebet, Thomas
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (03) : 307 - 317
  • [9] Hypomethylating Agents in Combination With Histone Deacetylase Inhibitors in Higher-Risk Myelodysplastic Syndromes: Is There a Light at the End of the Tunnel?
    Stahl, Maximilian
    Zeidan, Amer M.
    CANCER, 2017, 123 (06) : 911 - 914
  • [10] Histone Deacetylase Inhibitors in the Treatment of Lymphoma
    Lemoine, Manuela
    Younes, Anas
    DISCOVERY MEDICINE, 2010, 10 (54) : 462 - 470
12345